Medical News

RSS

New finding in studying dopamine transporter

Confirming findings in a previous study, Yale researchers observed an altered availability of the dopamine transporter in healthy persons with a genetic variation linked to substance abuse and attention deficit hyperactivity disorder (ADHD).

30 May 2005

Chemicals in food packaging linked to breast cancer

Chemicals found in some food packaging materials have been shown in a new study to affect the development of breast tissue in mice, which suggests, say scientists, that women exposed to such chemicals, which mimic female hormones, may be at increased risk of breast cancer.

30 May 2005

Health officials out to zap mozzies before the peak season

Even though no cases of West Nile virus have been reported so far this year, area health officials at the Virginia Department of Health are getting a head start on mosquitoes carrying such diseases before the peak breeding season arrives.

30 May 2005

Artificial cobweb proteins for medicine

A unique material based on cobweb proteins is being created by Russian researchers of the State Research Center of Russian Federation GosNIIgentics, Scientific Research Center “Coal-Chemical Fiber”, State Research Center of Applied Microbiology in cooperation with their colleagues from Michigan University with support form the International Science and Technology Center (ISTC) (project 1033.2).

30 May 2005

Sickle cell protects against malari

In this month's issue of the open access journal PLoS Medicine, Dr. Thomas N. Williams and colleagues from Kilifi, Kenya, show that the protection against malaria given by carrying the gene for sickle cell haemoglobin may involve the immune system.

30 May 2005

Targeted Genetics issued patent related to adeno-associated virus (AAV) technology platform

Targeted Genetics Corporation has announced the issuance of another patent related to the Company's leading adeno-associated virus (AAV) technology platform. U.S. patent #6,897,045, titled "Adeno-Associated Virus Vectors," was issued to the University of Iowa Research Foundation and is exclusively licensed to Targeted Genetics.

30 May 2005

Bioniche Life Sciences granted European patent

Bioniche Life Sciences has announced that it has had another patent granted on its core technology: Mycobacterial Cell Wall-DNA Complex (MCC). The European Patent Organization (EPO) granted the patent: - "Composition and Method for Inducing Apoptosis in Prostate Cancer Cells" (EPO1165106)

30 May 2005

Ranbaxy makes further three filings of its Anti-Retroviral (ARVs) formulations

Ranbaxy Laboratories Limited has announced that the Company has made further three filings of its Anti-Retroviral (ARVs) formulations, to the World Health Organization (WHO) for its approval under the latter's pre-qualification project for HIV/AIDS drugs.

30 May 2005

Asbestos Compensation Fund Legislation passed by Senate Judiciary Committee

The U.S. Senate Judiciary Committee is to be applauded for taking action to protect the rights of true victims of asbestos-related illness and ensure they promptly receive their full compensation, the Center for Individual Freedom said late last week.

30 May 2005

Flavonols in food, key to healthy eating?

University of Melbourne scientists may have found the secret of the fresh fruit and vegetables centred ‘Mediterranean diet’.

29 May 2005

A sudden increase in the number of British cases of Lyme disease

Lyme disease, an infection carried by ticks causes a rash and stiffness in the joints and, if left unchecked, it can affect the central nervous system, causing tingling in hands and feet, or facial palsy. In the worst cases the disease can also affect the heart, liver and spleen and even lead to encephalitis, which can kill.

29 May 2005

Fizzy drinks are the main source of calories in the U.S.

Tufts researchers recently reported that while the leading source of calories in the average American diet used to be from white bread, that may have changed.

29 May 2005

Technology for analyzing gene expression must be standardized

Technology for analyzing gene expression must be standardized among laboratories and across platforms around the world to support this age of human genome exploration, an Oregon Health & Science University researcher says.

29 May 2005

Emergence of cancer as a major cause of death among children in developing regions of the world is not being adequately addressed

This growing rate of pediatric cancer is occurring as the number of children dying from infectious diseases is being reduced through the efforts of the World Health Organization and international charities, the researchers say.

29 May 2005

Whole-body positron emission tomography/computed tomography scans may help physicians identify malignant cancerous tumors

A team of researchers at Johns Hopkins Medical Institutions in Baltimore, Md., reports that whole-body positron emission tomography/computed tomography (PET/CT) scans may help physicians identify new, unexpected malignant cancerous tumors in patients, according to an article in the May issue of the Society of Nuclear Medicine’s Journal of Nuclear Medicine.

29 May 2005

Leprosy microbes lead scientists to immune discovery

With the unusual opportunity that human leprosy infections provide for study of human immune responses, scientists have discovered how the body's early warning system prompts a rapid immune response by two separate armies of defensive cells.

29 May 2005

Doubts cast over India's AIDS figures

A controversy has erupted after Indian health workers have, expressed doubts over the new HIV/AIDS figures released by the government, they says the figures are too good to be true.

29 May 2005

Why good medications are sometimes bad for the liver

The University of North Carolina at Chapel Hill is one of five clinical centers nationwide to receive funds from the National Institutes of Health to study why good medications are sometimes bad for the liver.

29 May 2005

Adolescent depression can be as high as 20 percent

Teenage depression is widespread and can become a life-long illness, but is more often transitory, said UCLA Psychology Professor Constance Hammen, who discussed her research at the American Psychological Society's annual convention in Los Angeles.

29 May 2005

Discovery may lead to therapies to treat the neurological disease

Opening a window to understand the molecular basis of a hereditary ataxia, Dartmouth Medical School researchers have identified an enzyme activity that is inactivated in all reported mutant forms of a disease protein. The discovery may lead to therapies to treat the neurological disease.

29 May 2005